New Coronavirus Test Harnesses RT-LAMP Technology
The new RT-LAMP method uses patient-collected gargle lavage samples, producing results in less than an hour
In order to monitor and contain the spread of SARS-CoV-2 it is necessary to test large numbers of people on a regular basis in decentralized settings. Researchers at the Max Planck Institute for Evolutionary Anthropology and the Hospital St. Georg in Leipzig, Germany, have developed improved protocols for the detection of SARS-CoV-2. The method can detect a positive sample in a pool with 25 uninfected samples in less than one hour.
The new method was published March 5, 2021, in Nature Communications.
Quantitative real-time polymerase chain reaction (qPCR) is the most widely used diagnostic method to detect RNA viruses such as SARS-CoV-2, which causes COVID-19. However, qPCR requires expensive laboratory equipment and global shortages of reagents for RNA purification have increased the need to find simple but reliable alternatives.
One alternative to the qPCR technology is RT-LAMP (reverse transcription loop-mediated isothermal amplification). This test amplifies the desired target sequences of the virus at a constant temperature, using minimal equipment compared to qPCR.
Related Article: The Utility of Saliva Samples for Mass Population COVID-19 Screening
In 2020, it was adapted to the detection of SARS-CoV-2. It was also shown that instead of a nasopharyngeal swab, which many people find unpleasant, RT-LAMP can be performed on gargle lavage samples, which patients can collect themselves without putting heath care workers at risk.
First author Lukas Bokelmann and colleagues have now developed an improved colorimetric RT-LAMP assay, called Cap-iLAMP (capture and improved loop-mediated isothermal amplification), which extracts and concentrates viral RNA from a pool of gargle lavage samples. After a short incubation, the test result—orange/red for negative, bright yellow for positive—can be interpreted visually or by using a freely available smartphone app.
The improved testing method outperforms previous similar methods. "Cap-iLAMP drastically reduces false positives and single infected samples can be detected in a pool among 25 uninfected samples, thus reducing the technical cost per test to only about 1 Euro per individual," says senior author Stephan Riesenberg, a researcher at the Max Planck Institute for Evolutionary Anthropology. "Our method overcomes problems associated with standard RT-LAMP and could also be applied to numerous other pathogens."
- This press release was originally published on the Max Planck Society website